SecBot SecBot
8-K ·Filed Apr 2, 2026

HRMY

Harmony Biosciences Holdings, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed7mo ago SEC0001104659-26-038888
8-K context-dependent: Items 5.02, 7.01
Actionable Insight • Neutral

Monitor Anastasiou's integration into the executive team and his impact on operational execution. The leadership changes suggest a strategic shift toward strengthening operational capabilities, which could influence future growth initiatives.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$27.74
T+0 close · Apr 2, 2026 · via day close
Latest settled
+31.25%
T+60 · $36.41
Vs SPY
+17.09%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 2 $27.74entry
  2. T+1 · 8mo ago −0.11%α −0.58% · $27.71
  3. T+5 · 7mo ago +4.15%α +0.53% · $28.89
  4. T+20 · 7mo ago +12.69%α +2.81% · $31.26
  5. T+60 · 5mo ago +31.25%α +17.09% · $36.41
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Harmony Biosciences appointed Peter Anastasiou as Chief Operating Officer and board member Troy Ignelzi, while two directors, including Anastasiou and Antonio Gracias, stepped down. The company disclosed Anastasiou's employment agreement with a $600,000 base salary and $3.7 million equity grant.

Key Facts

  • Peter Anastasiou appointed as Senior Executive Vice President and Chief Operating Officer effective April 2, 2026
  • Anastasiou resigned from the board of directors upon becoming COO
  • Troy Ignelzi appointed to the board to fill Anastasiou's vacancy
  • Antonio Gracias will not stand for re-election at the upcoming annual meeting
  • Anastasiou's employment agreement includes $600,000 annual base salary
  • Anastasiou received an option grant with $3.7 million grant date fair value
  • Anastasiou will receive severance equal to one year of base salary if terminated without cause

Financial Impact

The company committed to $600,000 annual cash compensation and $3.7 million in equity compensation for the new COO

compensationequityoperating expenses

Risk Factors

  • Potential disruption from leadership transition
  • Increased compensation expenses from new executive hire

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-038888
Document: hrmy-20260331x8k.htm0001104659-26-038888
Document: hrmy-20260331xex99d1.htm0001104659-26-038888
Document: 0001104659-26-038888-index-headers.html0001104659-26-038888
Document: 0001104659-26-038888-index.html0001104659-26-038888
Document: 0001104659-26-038888.txt0001104659-26-038888

Track record

20 reports on HRMY

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +14.82% at T+20 after the Jul 16, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $33.21 Now $32.96 −0.75% settles Dec 15
  2. Nov 4, 202612d ago 8-K Bearish 5/10 No price data
  3. Nov 4, 202612d ago Press Release Bearish 5/10 Entry $34.42 Now $32.96 +4.23% settles Dec 3
  4. Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $37.02 Now $32.96 −10.97% settles Dec 2
  5. Oct 30, 202617d ago 8-K/A Neutral 3/10 Entry $37.91 Now $32.96 −13.06% settles Dec 1
  6. Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $38.50 Now $32.96 −14.39% settles Nov 25
  7. Oct 13, 20264w ago 8-K Neutral 3/10 Entry $37.03 to $33.55 Now $32.96 −10.99% ▼ −9.40% −5.79% vs SPY
  8. Oct 1, 20266w ago Press Release Neutral 3/10 Entry $39.57 to $38.59 Now $32.96 −16.70% ▼ −2.48% −3.18% vs SPY
  9. Aug 4, 202614w ago 8-K Bullish 7/10 No price data
  10. Aug 4, 202614w ago Press Release Bullish 6/10 Entry $38.78 Now $32.96 −15.01% No price data
Showing 10 of 20

US Market Status

Market Closed · Opens in 7h 41m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 2, 2026